Compounded tirzepatide
Brello Health vs MEDVi
Quick answer
The recorded cost for Brello Health is $197 per calendar month, while MEDVi costs $434 — a difference of $236 a month, or $2,838 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
Checked in . Prices can change; confirm the current price and billing terms before you pay.
Brello Health or MEDVi?
Brello Health costs less, $197 a calendar month against $434 at MEDVi. Only Brello Health reaches District of Columbia, Mississippi and North Dakota, while only MEDVi reaches Alabama, Arkansas, California, Connecticut and 12 more states, going by where each says it ships. Neither has an FDA warning letter on record.
What each one bills
| Brello Health | MEDVi | |
|---|---|---|
| True monthly cost | $197 | $434 |
| Advertised as | $166 | $279 |
| Charged | every 11 weeks | every 4 weeks |
| Each charge | $499 | $399 |
| Price basis | not stated | the same at every dose |
| Mandatory recurring fee | none found | none found |
| States it names | 35 states | 48 states |
| FDA warning letter | none on record | none on record |
Where they actually differ
- They bill on different clocks. Brello Health charges every 11 weeks and MEDVi charges every 4 weeks. That alone changes what a “month” costs, which is the whole reason this index recomputes every price.
- Check which dose each price covers. Brello Health: not stated; MEDVi: the same at every dose. See what titration does to an advertised figure.
- What they advertise is not what they bill. Brello Health advertises $166 and bills $197; MEDVi advertises $279 and bills $434.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Our verification method explains how the billing period and required recurring charges factor into the calculation.
To compare any two sellers in the index rather than these two, use the comparison tool.